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Abstract 
 
Previous research has indicated a critical role of task demand in 
determining driving outcomes amongst individuals with attention-deficit/ 
hyperactivity disorder (ADHD). These findings are derived predominantly 
from laboratory simulations. The objective of the present study therefore 
was to investigate the relationship between factors influencing demand 
and arousal in real traffic, and the performance of drivers medicated (n = 
15) and unmedicated for ADHD (n = 12), compared to a control group (n = 
17). Self-reported data relating to risky driving behaviours and driving 
history, and symptoms of ADHD in adulthood were collected. To 
determine the influence of demand on driving performance and errors, 
participants navigated a route incorporating rural, urban, residential, and 
highway environments. Relative to controls, unmedicated ADHD drivers 
employed fewer safe driving skills (p < .05), committed more inattentive (p 
< .05), and impatient driving errors (p < .01), and reported engaging in 
more frequent aggressive violations (p < .05). ADHD was associated with 
higher rates of crashes (p < .01) and multiple crashes (p = .05). Attesting 
to the efficacy of stimulant treatment, medicated ADHD driver 
performance in the present study was comparable to, if not better than 
controls. While unmedicated drivers undervalued the risk related to 
driving behaviours predictive of poor outcomes, medicated ADHD drivers 
largely overestimated the severity of their risky driving (p < .01). Demand 
was found to significantly impact the performance of unmedicated ADHD 
drivers particularly. Attention was best during high demand, urban driving. 
As environmental demand declined, more frequent attentional lapses 
occasioned increased impairment to performance (p < .01). Relative to 
drivers of automatic vehicles, high demand manual driving was linked 
with better hazard detection (p < .05) and overall performance (p < .05) 
amongst medicated drivers, and safer following distances amongst 
unmedicated ADHD drivers (p < .05). Apparently distinct driving styles 
were also revealed between ADHD subtypes. This is the first study to 
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document the impact of factors influencing task demand on ADHD driver 
performance in real traffic. Further exploration of the present findings 
could prove fundamental for future strategies of behavioural intervention.  
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Introduction 
Attention-deficit/ hyperactivity disorder (ADHD) is characterised by 
pervasive functional impairments related to inattention, hyperactivity, and 
impulse control (American Psychiatric Association, 2013). In adulthood, a 
critical presentation of dysfunction can be observed behind the wheel 
(Jerome, Segal, & Habinski, 2006). Adverse road safety outcomes were 
first broadly linked to a group of young hyperactive drivers in a 
longitudinal study by Weiss in 1979 (Weiss, Hechtman, Perlman, Hopkins, 
& Wener, 1979). It was Russell Barkley’s 1993 paper however that cast 
issues of ADHD and road safety to the fore, proposing a risk of collision 
nearly fourfold that of drivers without ADHD (Barkley, Guevremont, 
Anastopoulos, DuPaul, & Shelton, 1993). Researchers have since pursued 
one of two broad lines of enquiry; further establishing the risk relationship, 
and more recently, exploring the alleviating effects of medication on 
impaired driving.  
During adolescence, ADHD is associated with high rates of illegal 
driving prior to and post suspension of license, reception of repeated 
driving infringements; most commonly for excess speed, and reduced 
employment of safe driving practices (Barkley et al., 1993; Fischer, 
Barkley, Smallish, & Fletcher, 2007; Narad et al., 2013; Woodward, 
Fergusson, & Horwood, 2000). Drivers with ADHD are involved in more 
collisions, and are more likely to be found at fault in these collisions 
(Merkel et al., 2013). Furthermore, collisions that involve an ADHD driver 
are associated with outcomes of greater harm or injury than those 
involving drivers without ADHD (Woodward et al., 2000). ADHD drivers 
also make more insurance claims, at a greater overall cost per claimant 
(Swensen et al., 2004). They report more frequent engagement in risky 
behaviours predictive of poor outcomes on the road, demonstrate 
scepticism with regard to consequence, hold optimistic expectations of 
risk taking behaviours, and are disinclined to pursue measures of injury 
prevention (Farmer & Peterson, 1995; Fried et al., 2006; Knouse, Bagwell, 
Barkley, & Murphy, 2005; Merkel et al., 2013).  
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Pharmacological treatment measures currently represent the most 
effective intervention option for drivers with ADHD, and are underpinned 
by a vast and robust research base. Research conducted in real traffic 
suggests that medication leads to improvements in basic driving skills 
(Sobanski et al., 2013), fewer instances of inattention and impulsivity 
(Cox, Humphrey, Merkel, Penberthy, & Kovatchev, 2004a; Sobanski et al., 
2013), and reduced involvement in erratic driving events and collisions 
(Cox et al., 2012). These studies tend to be exclusively outcome driven 
however, offering definitive comparisons of performance pre- and post-
intervention without reflection upon the functions underlying risk. As a 
result, important attributes of the driving experience that can both nurture 
and impede sustained attention; an innate feature of ADHD, remain 
relatively uncharted (Reimer, Mehler, D'Ambrosio, & Fried, 2010). 
Sustained attention in the presence of distraction is critical for 
coherent cognitive function (Lavie, 2005). This can, however, present an 
incredible challenge for individuals with ADHD, particularly during periods 
of low arousal (Forster, Robertson, & Jennings, 2014). As a task requiring 
sustained attention, driving is therefore also susceptible to the influences 
of distractibility and arousal associated with ADHD. The past decade has 
seen emergence of behavioural research and intervention strategies that 
point to the critical role of demand in determining attention and 
performance amongst individuals with ADHD (Cox et al., 2006b; Forster 
et al., 2014; Reimer, D’Ambrosio, Coughlin, Fried, & Biederman, 2007; 
Reimer et al., 2010).  
The following review will summarise several influences of 
performance amongst the ADHD driving population. Studies of both 
pharmacological and behavioural strategies of intervention are discussed. 
Factors that serve to further jeopardise driving outcomes, such as 
comorbid conditions, overestimation of driving ability, and aggression are 
then described. Finally, the possibility that differential symptom 
presentations might engender a distinction of diagnostic subtype driving 
styles amongst the ADHD groups is considered.  
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Pharmacological Intervention 
Various stimulant and non-stimulant treatments have been 
demonstrated to improve performance amongst the ADHD driving 
population (see Table A1 for an overview of the studies and their 
outcomes). The stimulant methylphenidate (MPH) currently represents the 
most commonly prescribed medication in New Zealand, and is 
recommended as a first line intervention for individuals with ADHD (see 
Table 1; PHARMAC, 2014). MPH is available in a range of dosages and 
release forms. While immediate release forms require multiple 
administrations across the day, sustained release MPH is ingested just 
once daily (PHARMAC, 2014). Researchers describe differential efficacy 
based on MPH release form.  
 
 
Table 1 
Pharmacotherapy of ADHD and its use in New Zealand 
 
Medication Drug name Form Use in New Zealand Duration 
Mixed Amphetamine Salts  
(MAS-XR) 
Adderall 
 
Dexamphetamine, Levoamphetamine 
extended release 
Not available  
 
8 – 12 hours 
 
Dexamfetamine (DEX) 
 
PSM/  
Dexedrine 
Dexamphetamine sulphate 
short acting 
Fully subsidised 
 
4 – 6 hours 
 
Methylphenidate (MPH) 
 
Rubifen IR a 
 
Methylphenidate Hydrochloride 
immediate-release 
Fully subsidised 
 
3 – 4 hours 
 
 Rubifen SR  
Methylphenidate Hydrochloride  
sustained-release 
Fully subsidised 
 
4 – 8 hours 
 
 Ritalin IR a Methylphenidate Hydrochloride immediate-release 
PHARMAC funding ceased  
Now Rubifen SR 
3 – 4 hours 
 
 Ritalin SR Methylphenidate Hydrochloride intermediate acting 
Fully subsidised 
 
4 – 8 hours 
 
 Ritalin LA Methylphenidate Hydrochloride  modified, intermediate-release  
Fully subsidised 
 
8 – 10 hours 
 
Methylphenidate (MPH) 
Extended-release 
Concerta XR 
 
Methylphenidate Hydrochloride  
osmotic-controlled release 
Fully subsidised 
 
 
10 – 12 hours 
 
 
Methylphenidate  
Transdermal (MTS) patch 
Daytrana patch 
 
Methylphenidate Hydrochloride 
transdermal-release system 
Not available 
 
10 – 12 hours 
 
Lisdexamfetamine (LDX) Vyvanse Lisdexamfetamine  Not available 10 – 12 hours 
Atomoxetine (ATX) Strattera b Atomoxetine Second line treatment 24 hours 
Note. a Considered bioequivalent. b  Non-stimulant. 
 
 
Table 2 
Group demographic and driving characteristics 
 Age Licensed driving experience  
Average weekly 
mileage  Gender License type Transmission  
  Male Restricted Full Automatic Manual  
Control 30.24 (3.31) 146.41(36.36) 210.00 (34.89) 6 (35%) 2 (11%) 15 (88%) 13 (72%) 4 (28%) 
Medicated ADHD 38.73 (3.52) 197.07 (43.99) 206.00 (68.04) 7 (47%) 3 (14%) 11 (73%) 9 (60%) 6 (40%) 
Unmedicated ADHD 38.67 (3.83) 206.67 (51.76) 223.33 (41.31) 9 (75%) 0 (0%) 12 (100%) 6 (50%) 6 (50%) 
Total 35.43 (2.09) 180.11 (24.67) 212.27 (28.44) 22 (49%) 5 (13%) 39 (87%) 28 (59%) 16 (41%) 
Note. Mean (SE) or n (%) ! !
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MPH Immediate-Release (MPH-IR). 
Several researchers have explored the effect of MPH-IR on ADHD 
driver performance (Barkley, Murphy, O’Connell, & Connor, 2005; Cox, 
Merkel, Kovatchev, & Seward, 2000; Verster et al., 2008). Cox and 
colleagues (2000) assessed the simulated driving performance of drivers 
with and without ADHD after administration of a single 10 mg dose of 
MPH-IR compared to placebo. While performance was considerably 
poorer compared to controls during the placebo condition, ADHD drivers 
performed as well as controls during treatment with MPH-IR. Objective 
performance ratings were corroborated by self-reports of safer driving 
skills (Cox et al., 2000).  
Verster et al. (2008) used a camera system to examine the effects 
of MPH-IR on driving in real traffic. Participants drove a test vehicle 
across a fixed, 100 km highway route (Verster et al., 2008). Although 
driving was described by participants as improved and less effortful 
during treatment with MPH-IR, only a minimal improvement in lane 
deviation was obtained (Verster et al., 2008). In another study, Barkley 
investigated the effects of high (20 mg) and low (10 mg) doses of MPH-IR 
on simulated driving performance compared to placebo (Barkley et al., 
2005). Participants performed best when treated with the higher dose of 
MPH-IR.  
MPH Osmotic-controlled Release Oral System (MPH-OROS). 
In a study of treatment with MPH-OROS, ADHD drivers navigated 
a 25 km route in real traffic whilst accompanied by a blind observer (Cox 
et al., 2004a). MPH-OROS was found to significantly improve observer-
reported engagement in inattentive errors compared to a no-drug 
condition. In another study, Cox et al. (2006a) compared the effects of the 
stimulants MPH-OROS and mixed amphetamine salts (MAS-XR) on 
simulated driving performance compared to placebo. MPH-OROS was 
associated with significantly improved performance compared with 
placebo and MAS-XR, resulting in reduced lateral lane deviation, less 
speeding, speed variability, and unnecessary braking (Cox et al., 2006a).  
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MPH Transdermal System (MPH-MTS). 
Just one study of MPH-MTS was identified (Cox et al., 2012). Cox 
and colleagues (2012) used a DriveCam in-car video monitoring system to 
measure the performance of 17 participants with ADHD over 6 months of 
routine driving. The DriveCam system stored footage recorded 10 s 
before and after accelerometer detected change in g-force events, 
capturing erratic events such as abrupt braking, rapid acceleration, 
impact, and swerving (Cox et al., 2012). Three months of data was 
collected at baseline, and three months during treatment with a 10 to 30 
mg MPH-MTS patch applied once daily. No collision events were 
recorded during MPH-MTS treatment, compared to a total of 8 during no-
drug driving (p < .005). Drug compliance presented a considerable issue 
however, with participants only using MTS about half the time (Cox et al., 
2012). 
 Lisdexamfetamine (LDX). 
Two studies have explored the effect of LDX on driving, both of 
which are based on the same sample of 61 outpatients (Biederman et al. 
2012a, 2012b). Participants drove a 43 mile (69 km) simulated route 
incorporating a range of environments at baseline, and after 6 weeks of 
treatment with either LDX or placebo (Biederman et al. 2012a, 2012b). 
Five surprise events required drivers quickly act to avoid collision. Dual 
task conditions were introduced during high stimulus, urban, and low 
stimulus highway driving. Treatment with LDX improved reaction times to 
surprise events, and reduced collisions compared to placebo. Collisions 
mostly occurred during the final period of low-stimulus driving, 
suggesting increased vulnerability to distraction when environmental 
demand is low. In a second study, Biederman et al. (2012b) assessed the 
impact of LDX treatment on self-reported risky driving behaviours using 
an adaptation of the Manchester Driving Behaviour Questionnaire (DBQ). 
Participants treated with LDX reported engaging in fewer errors (p = 0.02), 
lapses (p = 0.02), and total risky driving behaviours (p = 0.01) compared 
to placebo (Biederman et al., 2012b).  
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Mixed Amphetamine Salts (MAS-XR). 
Kay, Michaels, & Pakull (2009) examined simulated driving 
performance amongst 19 young adults with ADHD during treatment with 
MAS-XR 50 mg/day and ATX 80 mg/day compared to placebo. MAS-XR 
significantly reduced collisions, lateral lane deviation, and reaction times 
compared to placebo (Kay et al., 2009). Improvements were sustained up 
to 12 hours post ingestion. It was reported that 75% of participants 
experienced adverse side effects of treatment (Kay et al.). In another 
study, a previously sampled group of drivers (Cox et al., 2006a, 2008) 
was employed to explore gender variability in stimulant effectiveness and 
tolerability (Mikami et al., 2009). It was found that both genders 
experienced equivalent treatment efficacy, tolerability, and side effects of 
MAS-XR (Mikami et al., 2009).  
Atomoxetine (ATX). 
Research to date presents inconclusive outcomes relating to 
treatment with the non-stimulant ATX. Kay et al. (2009) reported no 
significant improvements in driving simulator safety scores 2, 7, or 12 
hours post ingestion compared to placebo. In a similar study of ATX 
treatment, participants described subjective improvements in ADHD 
symptoms and simulated driving performance, however observer ratings 
did not significantly improve compared to placebo (Barkley, Anderson, & 
Kruesi, 2007). Both studies assessed participants after 3 or 4 weeks of 
treatment (Barkley et al., 2007; Kay et al., 2009), however, ATX may take 
as long as 12 weeks to reach full efficacy (Sobanski et al., 2013). In a 
recent, sponsored trial of ATX, a larger sample of participants received 12 
weeks of treatment with ATX before on road assessment. An 
accompanying observer scored driver performance as participants 
navigated a fixed, 45-minute, urban route in rush hour traffic. Observer-
reports of attention to the driving task and employment of safe driving 
skills were best amongst drivers treated with ATX compared to a group of 
waiting-list, ADHD controls (Sobanski et al., 2013).  
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Delivery profiles. 
Four studies have explored the delivery profiles of drug treatment 
(Cox et al., 2000; Cox, Merkel, Penberthy, Kovatchev, & Hankin, 2004b, 
Cox et al., 2006a; Kay et al., 2009). In these studies, the participants 
drove an assessed route up to four times in one day following ingestion of 
a drug treatment. Performance was then compared across time to 
establish a treatment delivery profile. One study compared the effect of 
immediate and extended release MPH on ADHD driver performance at 
night (Cox et al., 2004b). While improvements with MPH-OROS 
demonstrated no indication of deterioration, MPH-IR was associated with 
more inappropriate braking on the open road, failure to yield at stop 
signs, and erratic speed control. 
Cox and colleagues (2006a) assessed performance at 17:00, 
20:00, and 23:00 during treatment with MPH-OROS, MAS-XR, or placebo 
(Cox et al., 2006a). Improvements in driving performance with MPH-
OROS were sustained as late as 23:00. An all male subsample of the 
same study was able to demonstrate the sustained efficacy of both MAS-
XR and MPH-OROS on simulated driving performance as late as 1:00 am 
(Cox et al., 2008). No decay of simulated driving performance was evident 
up to 17 hours after ingestion. In real traffic however, an in-car observer 
noted more frequent inattentive errors with MAS-XR compared to 
placebo (p =0.04), suggestive of a possible rebound effect on the road 
(Cox et al., 2008).  
Behavioural Intervention 
At present, there exist scarce options for ADHD drivers who 
choose not to take medication. Development of strategies for effective 
behavioural intervention will appeal to many. Rather than concealing the 
functions that underlie risk, behavioural strategies are predicated upon 
the understanding of such functions, and are more likely to encourage 
long-term employment of safer driving habits and behaviours, and 
awareness of ADHD related deficits and vulnerabilities. Further, such 
intervention does not rely on whether a driver takes their medication, or 
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the timing of administration, but can also be used adjunctively with 
medication to reduce risks at night time, during drug holidays, or between 
administrations (Gobbo & Louza, 2014).  
An overview of researched strategies of behavioural intervention is 
provided in Table A2. Targeted interventions such as hazard perception 
training have been shown to improve certain driving skill sets (Poulsen, 
Horswill, Wetton, Hill,  & Lim, 2010). To truly rival the factors that elevate 
risk on the road however, behavioural strategies must foremost address 
the imposing symptoms of distractibility that compromise outcomes 
amongst individuals with ADHD (Lavie, 2005).  
Recent research points to a critical role of task demand in 
determining an individual’s ability to focus attention (Reimer et al., 2010). 
Sustaining attention in the presence of competing distractor stimuli 
requires greater effort and cortical activation than that required of 
individuals without ADHD (Forster et al., 2014). As a result, individuals 
with ADHD experience twice the distractor interference experienced by 
those without ADHD (Forster et al., 2014). Mediating the ability of a 
particular individual with ADHD to sustain attention however is the level 
and load of the primary task (Lavie, 2005). When task demands compel 
optimal levels of arousal, distractor interference is minimal. Environments 
that are low in demand, or lacking stimulation however, lead to 
involuntary processing of distractor stimuli, thus impairing attention and 
performance (Forster et al., 2014; Loo et al., 2009).!Several studies have 
investigated performance under low and high demand conditions 
(Laberge, Ward, Manser, Karatekin, & Yonas, 2005; Reimer et al., 2007; 
Reimer et al., 2010).!
Dual task conditions. 
In a study by Reimer and colleagues (2010), participants 
completed measurable secondary distractor tasks introduced during 
periods of low and high stimulus driving to determine the influence of 
demand on distractibility. Financial incentives required participants 
balance rewards earned for secondary task performance against rewards 
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lost for poor driving (Reimer et al., 2010). ADHD driver performance 
suffered considerably when presented with a secondary cognitive task 
during low stimulus driving, resulting in greater distances travelled in 
excess of the speed limit, and increased speed variability compared to a 
control group (Reimer et al., 2010). Improved performance on the 
secondary challenge, a continuous performance task (CPT), suggests 
poor regulation of attention between the primary driving and secondary 
distractor task. Under high stimulus driving conditions however, driving 
performance was analogous between driver groups, indicating that ADHD 
drivers were able to effectively regulate the attentional demands of the 
secondary task. This points to the significance and utility of driving 
environment in both understanding and predicting ADHD driver 
distraction and performance (Reimer et al., 2010). Under less demanding 
driving conditions, poor task regulation may predispose ADHD drivers to 
invest more attention toward a distraction in the driving environment, thus 
compromising their driving performance (Reimer et al., 2010).  
Cognitive distraction. 
Other studies have investigated distractibility during periods of low 
and high demand, without introduction of an overt secondary task or 
distraction. Biederman et al. (2012a) explored the effect of environmental 
demand on simulator based impaired driving amongst individuals with 
and without ADHD. Participants completed a 45 minute simulated route 
incorporating periods of high demand urban driving, and low demand, 
monotonous rural and highway driving. Hazardous events presented 
throughout the drive required quick evasive action in order to avoid a 
collision. During a second monotonous period, ADHD drivers were 
significantly more likely to collide with a hazard presented in the periphery 
than were controls, suggesting impaired ability to sustain attention when 
environmental demand is low (Biederman et al., 2012a).  
A laboratory study of non-ADHD drivers varied weather conditions 
to manipulate demand (He, Becic, Lee, & McCarley, 2011). Participants 
drove a straight, dull rural road designed to encourage mind wandering 
! 10 
(He, Becic, Lee, & McCarley, 2011). To determine the effect of task 
demand on the frequency of mind wandering, the route was completed 
during fine weather, and heavy wind conditions (He et al., 2011). Whilst 
heavy winds resulted in greater attention to the driving task, participants 
reported more frequent mind wandering during the fine weather condition 
(He et al.).  
Transmission. 
An array of conditions have been utilised in research to manipulate 
demand (Biederman et al., 2012a; He et al., 2011; Reimer et al., 2010). 
Just one study, however, has established an intervention condition that 
engages the ability to improve performance during high demand driving 
(Cox et al., 2006b). In a pilot study of the impact of vehicle transmission 
on driving performance, 10 adolescents with ADHD drove a simulated 
route in both automatic and manual transmission modes (Cox et al., 
2006b). An impaired driving score compiling measures of steering and 
speed control, and braking reactions was calculated. Drivers self-
reported attending best to the driving task during manual driving (Cox et 
al., 2006b). Impaired driving scores were also found to improve compared 
to automatic driving. Increased task demand is proposed to underlie the 
efficacy of this intervention, as effective operation of a manual 
transmission vehicle requires more frequent attention to the driving 
process (Cox et al., 2006b). Participants must monitor and control their 
speed and tachometer readings using the clutch, accelerator, brake, and 
gear stick, thus sustaining attention to the driving task, and evading the 
distractibility effect experienced in low demand tasks and environments. 
Recommending individuals with ADHD choose to drive vehicles with a 
manual transmission represents a simple and encouraging behavioural 
intervention for adolescents with ADHD, particularly those who are 
considering purchasing their first vehicle (Cox et al., 2006b).  
Amongst ADHD drivers, performance appears to be best during 
periods of increased demand and arousal. When demand is high, 
vulnerability to distraction is reduced, and drivers are able to sustain 
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attention to the driving task (Biederman et al., 2012b; Cox et al., 2006b; 
Reimer et al., 2010).  
Non-driving studies. 
Several non-driving studies have also introduced a high demand 
intervention condition to improve performance amongst individuals with 
ADHD. Söderlund utilised moderate auditory white noise to increase 
environmental demand, observing improved performance on a cognitive 
challenge amongst ADHD participants compared to a no noise condition 
(Söderlund, Sikström, & Smart, 2007). In contrast, control group 
performance was impaired under the noise condition compared to no 
noise.  
Forster et al. (2014) examined the influence of perceptual load 
(demand) on the distractibility of adults with ADHD compared to a control 
group. Participants were to identify target stimulus in a letter search 
display, and ignore colourful distractor images presented in the periphery. 
The size of the search set was increased to manipulate demand (Forster 
et al.). At baseline, the presence of distractor stimuli significantly impaired 
the response times of adults with ADHD compared to controls (Forster et 
al.). By increasing the search set size, hence increasing task demand; 
distractor interference was significantly reduced (Forster et al.).  
Such research imparts that individuals with ADHD are capable of 
effectively resisting distraction when a primary task is perceived to be 
sufficiently compelling (Forster et al., 2014; Reimer et al., 2010; Söderlund 
et al., 2007). However, conditions lacking in demand are likely to 
encourage increased distractibility from the primary task, and less optimal 
performance outcomes.  
Further Influences of Performance 
As well as vulnerability to distraction during low demand 
conditions, further factors serve to influence the performance of drivers 
with ADHD. ADHD is associated with a high prevalence of comorbid 
conditions, overestimation of ability; and aggressive driving tendecies, all 
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of which are known to increase the likelihood of adverse outcomes on the 
road (Knouse et al., 2005; Nada-Raja et al., 1997). 
Comorbid conditions. 
Comorbidity is a common clinical feature of ADHD, and can 
confound estimates of risk associated with the condition on the road 
(Fried et al., 2006; Jerome et al., 2006; Murphy & Barkley, 1996; Nada-
Raja et al., 1997; Spencer, Biederman & Mick, 2007; Vaa, 2014). Common 
comorbidities such as Oppositional Defiant Disorder (ODD), Conduct 
Disorder (CD), alcohol and substance abuse are established predictors of 
poor driving outcomes (Jerome et al., 2006). Comorbid conduct problems 
are associated with both risky and alcohol-impaired driving amongst 
adolescents and young adults with and without ADHD (Thompson, 
Molina, Pelham, & Gnagy, 2007). In a New Zealand longitudinal study of 
inattentive and hyperactive behaviours and driving during adolescence, 
high rates of driving infringements correlated most strongly with either 
ODD or CD amongst males (Nada-Raja et al., 1997). Impaired driving 
measures were also found to interact significantly with a comorbid 
diagnosis of either ODD or CD in a study by Barkley and colleagues 
(1993), however the researchers were unable to calculate the relative 
contributions of these conditions. In a meta-analysis of the relative risk of 
accidents associated with ADHD in road traffic, Vaa (2014) estimated risk 
to be 1.86 (1.27; 2.75) amongst ADHD-drivers when the prevalence of 
comorbid ODD or CD was high, compared to 1.31 (0.96; 1.81) in a sample 
of ADHD-drivers with no comorbidity. 
Overestimation of competence. 
Individuals with ADHD have been shown to hold elevated 
perceptions of self-competence compared to individuals without ADHD 
(Owens, Goldfine, Evangelista, Hoza, & Kaiser, 2007). Such positive 
illusory bias serves to further encourage poor outcomes in multiple 
domains (Bruce, Ungar, & Waschbusch, 2009; Hoza, Waschbusch, 
Pelham, Molina, & Milich, 2000). Knouse et al. (2005) compared self-
appraisals of simulated driving performance amongst individuals with and 
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without ADHD. Despite employing fewer safe driving behaviours, ADHD 
participants rated their own performance similarly to controls (Knouse et 
al., 2005). Overestimation of ability amongst individuals with ADHD has 
also been associated with reduced admission of consequence, more 
positive expectations of risk taking behaviours, and little inclination to 
pursue measures of injury prevention (Farmer & Peterson, 1995; Knouse 
et al., 2005).  
Driver aggression. 
Oliver and colleagues investigated the influence of aggression on 
driving performance amongst young adults scoring high and low on a 
measure of ADHD symptomology (Oliver, Nigg, Cassavaugh, & Backs, 
2012). Measures of heart and respiration rate, simulated driving 
performance, and self-reported driving anger were obtained (Oliver et al., 
2012). Participants drove a simulated route at baseline, and again in 
heavy traffic, with introduced trigger events and a time incentive to 
simulate frustrating driving conditions (Oliver et al.). During frustrating 
driving, a high ADHD symptom score was significantly associated with 
failure to stop at red lights, involvement in collisions, and multiple 
collisions. This suggests that high symptom ADHD drivers are more 
impaired by the experience of frustration than low symptom drivers, 
resulting in maladaptive and impulsive risk-taking behaviours (Oliver et 
al.).  
Subgroups of high ADHD symptom drivers were established based 
on involvement in multiple vehicular collisions. Greater experience and 
expression of anger was strongly related to the experience of multiple 
collisions amongst this group (Oliver et al.). Further, high ADHD symptom 
drivers who had not been involved in multiple collisions reported less 
frustration at baseline than both low symptom drivers, and ADHD drivers 
involved in multiple collisions. This also suggests that a more calm and 
unperturbed disposition may serve as a protective factor, reducing the 
risk of poor outcomes amongst ADHD drivers (Oliver et al.).  
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Diagnostic subtype. 
It has been indicated that characteristics such as aggression are 
differentially associated with the various symptom presentations of ADHD 
(Derefinko et al., 2008; Dowson & Blackwell, 2010). Three subtypes of 
ADHD are recognised in the fourth and fifth editions of the Diagnostic and 
Statistical Manual for Mental Disorders (DSM-IV, DSM-5; American 
Psychiatric Association, 1994, 2013). Individuals diagnosed with ADHD, 
Predominantly Inattentive Type (ADHD-PI) present symptoms of 
inattention only. Those diagnosed with ADHD, Predominantly 
Hyperactive-Impulsive Type (ADHD-HI) present symptoms of 
hyperactivity and impulsivity only, and finally, those diagnosed with 
ADHD, Combined Type (ADHD-CT) present clinical symptoms of both 
inattention and hyperactivity-impulsivity (American Psychiatric 
Association, 2013).  
Symptoms of hyperactivity (ADHD-HI, CT) are associated with 
more externalised, conduct related problems, whereas ADHD-PI 
individuals are more likely to present with comorbid internalising 
disorders (Derefinko et al., 2008). Rather than the quick, impulsive 
response style associated with hyperactive-impulsive symptoms (ADHD-
HI, CT), individuals with ADHD-PI demonstrate a slow and variable 
response style, and more severe impairments of sustained attention 
across multiple contexts. Although subtype differences related to driving 
style have seldom been explored, it would be reasonable to anticipate 
that the presentation of symptoms of inattention as opposed to 
hyperactivity or impulsivity might predispose subtypes to differential 
driving impairments (Barkley, Murphy, DuPaul, & Bush, 2002; Dahlen, 
Martin, Ragan, & Kuhlman, 2005). 
Summary 
Individuals with ADHD are at an increased risk for poor outcomes 
on the road. Amplifying factors such as comorbid conditions, aggression, 
and overestimation of competence appear to further elevate risk (Knouse 
et al., 2005; Oliver et al., 2012; Vaa, 2014). Pharmacological treatment 
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measures have been demonstrated to reduce such risk both in simulator 
and real traffic settings (see Table A1 for a review). While the efficacy of 
drug treatment might be considered rationale for the current dominance 
of pharmacological research, it is likely too that the affluence of 
pharmaceutical company funding has curbed research ventures outside 
of the pharmacological sphere (Gobbo & Louza, 2014). A large number of 
pharmacological studies receive industry funding, with seven of the 
reviewed trials funded completely by the pharmaceutical company 
manufacturing the drug  (Cox et al., 2004a, 2004b, 2006a, 2012; Kay et 
al., 2009; Biederman et al., 2012a, 2012b).  
While drug treatment effectively conceals the influences of risk and 
resilience that operate within the driving experience, there is much to be 
learned from the exploration of such factors. Findings related to the 
influence of task demand on sustained attention not only suggest that 
individuals with ADHD are capable of effectively resisting distraction 
when a primary task is perceived to be sufficiently compelling, but more 
importantly, they demonstrate the capacity to manipulate demand in 
order to encourage such outcomes (Forster et al., 2014; Reimer et al., 
2010).  
The Present Study 
The objective of this study is to assess the relationship between 
driving performance and cognitive factors related to sustained attention in 
real traffic. Previous research has suggested a crucial role of task 
demand in determining driving outcomes for the ADHD driving 
population. This research has predominantly come from laboratory 
simulations, thus how various elements of the driving experience interact 
with attention to determine performance in real traffic situations has not 
yet been established (Reimer et al., 2010).  
The present study compared the driving performance of individuals 
medicated for ADHD, unmedicated ADHD drivers, and non-ADHD 
controls. Although simulator studies have typically introduced secondary 
distractor tasks and risk events to manipulate driver arousal, the impact 
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of different types and levels of arousal was explored using naturally 
occurring driving events. This approach afforded greater realism while 
avoiding ethical and safety issues that would have resulted from 
presentation of secondary challenges in real traffic. Participants navigated 
a driving route incorporating rural, urban, residential, and highway 
environments in their own cars to reduce novelty effects. To examine 
potential group differences related to positive illusory bias, self-reported 
measures of risky driving behaviour and driving history were also 
obtained and contrasted with observer reports.  
Given the established link between ADHD and risk on the road, it 
was hypothesised firstly that driving impairments would present most 
amongst ADHD drivers relative to controls. As the capacity to improve 
driving performance with drug treatment is now well established, it was 
also expected that medicated ADHD drivers would perform better than 
those from the unmedicated ADHD group. In addition, overestimation of 
ability amongst the unmedicated ADHD group was expected to result in 
differences in the congruence of self and observer-reported measures of 
risky driving behaviours and driving history between groups.  
Cognitive factors influencing task demand, such as vehicle 
transmission, and driving environment were expected to impact driving 
performance amongst drivers with ADHD particularly, resulting in 
improved attention and performance when environmental demand was 
high; such as during driving in high stimulus urban environments, and 
increased vulnerability to distraction and impaired performance when 
demand was low; such as dull periods of rural or highway driving.  
High levels of driving related aggression was expected to be 
associated with poorer driving outcomes, and although largely 
unexplored, differences related to driving style as a function of diagnostic 
type were anticipated to present amongst the ADHD groups, with more 
errors attributable to inattention, but few impatient or aggressive errors 
amongst Predominantly Inattentive drivers in relation to Hyperactive-
Impulsive and Combined type drivers.! !
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Method 
Participants 
Three driver groups were recruited from across the North Island of 
New Zealand for this between-groups study; a group medicated for 
ADHD, an unmedicated ADHD group, and a non-ADHD control group. 
Poster advertisements (see Appendix B) were placed on healthcare 
noticeboards, circulated via mailing lists, and presented at ADHD Adult 
group meetings to recruit the experimental groups. Control group 
participants were recruited through advertisements on community and 
university notice boards. All participants were required to hold a current 
restricted or full New Zealand drivers license and have access to a 
registered and warranted motor vehicle.  
The control group was made up of 17 drivers (11 female, 6 male) 
without a diagnosis of ADHD or history of taking stimulant medication. 
These participants were aged between 19 and 57, held either a restricted 
(n = 2) or full (n = 15) NZ drivers license, and reported between 12 and 
436 months of licensed driving experience. Thirteen participants drove a 
vehicle with an automatic transmission vehicle and 4 drove a manual 
vehicle. Control group participants drove between 30 and 500 kilometres 
in an average week.  
Drivers in both ADHD groups had been formally diagnosed with 
ADHD prior to their involvement in the study. Seven male and 8 female 
medicated ADHD drivers aged 17 to 67 were recruited for the medicated 
ADHD group, and instructed to take their medication as normal on the 
day of assessment. Prescribed medications included Concerta® (n = 5), 
Ritalin SR® or LA® (n = 9), and Rubifen SR® (n = 1). Six of the participants 
in this group drove a manual transmission vehicle, and 9 an automatic, 
driving between 20 and 1000 kilometres in an average week. Participants 
reported between 8 and 452 months of licensed driving experience. Two 
participants held a restricted and 13 a full NZ drivers license at the time of 
their participation in the study.  
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ADHD diagnosed drivers who had not taken medication in the 
month prior to and during assessment were allocated to the unmedicated 
ADHD group. Nine males and 3 females aged 21 to 65 comprised the 
unmedicated group, reporting between 17 and 564 months of licensed 
driving experience. All held a full NZ drivers license, and drove between 
10 and 500 kilometres in an average week. Six drove a vehicle with a 
manual transmission, and 6 drove an automatic vehicle. Ten participants 
reported having been prescribed one or more treatment for ADHD in the 
past, including Dexamfetamine (n = 2), Concerta® (n = 2), Ritalin IR® (n = 
2), Ritalin SR® (n = 3), Rubifen SR® (n = 2), and Strattera® (n = 2). 
 To control the potentially confounding effects of comorbid 
diagnoses, participants were asked to note any diagnosed health 
conditions. None of the participating drivers had received a diagnosis of 
oppositional defiant disorder (ODD) or conduct disorder (CD). 
Recruitment and testing protocols were approved by the University of 
Waikato School of Psychology Human Research and Ethics Committee. 
Driving Performance Measures 
Driving routes. 
A naturalistic method was employed to collect on-road driving 
performance data. A total of 10 driving routes were established. These 
were located in Hamilton, Tauranga, and at 8 locations across the wider 
Auckland region including Orewa, Rothesay Bay, Ponsonby, Epsom, 
Ellerslie, Henderson, Botany Downs, and Pakuranga (see Appendix C for 
driving routes). Each route was specifically designed to incorporate 
driving in rural, urban, suburban, and highway environments.  
Rural driving was defined as driving through areas used for 
agriculture, forestry, or reserves; or land outside towns and cities, where 
the level of roadside development is minimum (NZTA, 2003). Highway 
environments represent all state highway, motorway, and expressway 
where the speed limit is between 80 and 100 km/h (NZTA, 2003). In many 
cases these roads had upwards of 2x2 lanes. Residential environments 
were those developed and used primarily for housing. Urban driving 
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occurs in traffic areas close to or within a town or city, where land 
appears fully built-up (NZTA, 2003). In such areas a speed limit of 50km/h 
is indicated as drivers “can expect to encounter vehicles that are turning, 
slowing, stopping or parking, pedestrians, cycles and heavy vehicles” 
(NZTA, 2003). All routes therefore required at some point the participant 
to drive speeds ranging at minimum from 50-80 km/h. Several driving 
routes included road works where drivers were to drop to 30 km/h, and 
others highway driving where the speed limit was 100 km/h. At 
assessment locations throughout each driving route, drivers were 
required to perform one of 5 specific driving tasks (for task diagrams, see 
Appendix D): 
1. Right turn at a roundabout 
2. Right turn into a side street 
3. Right turn at a controlled intersection  
4. Left turn at a controlled intersection 
5. Lane change left or right 
Where practicable, the driving routes were designed to ensure 
each task was performed at 2 locations across the drive. 
Scoring the specific driving tasks. 
To score the specific driving tasks, performance was partitioned 
into measures of observation, comfort, following distance, signalling, gap 
selection, hazard detection, hazard response, and speed (NZTA, 2012). 
Each measure was compiled of items describing driving behaviours 
required to safely perform the driving task. Participants received 1 point 
for successfully carrying out the described safe driving behaviour. Failure 
to complete that behaviour resulted in a score of 0, and behaviour 
performed to a half standard, a 0.5. Operationally defined behaviours for 
each task were established to ensure consistency across participants 
(see Appendix E).  
At each of the specified driving tasks, a mean score for each 
measure, and an overall performance score were calculated. The driving 
observer also noted whether the roadway was rural, urban, residential, or 
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highway to enable comparison of performance scores by driving 
environment. 
Classification of errors. 
A score of zero on a specific driving task was indicative of an error; 
a failure to meet standards for the safe performance of a task. Errors were 
classed as inattentive, impatient, or aggressive. The score for each of 
these errors was dependent on the risk involved. If an event or behaviour 
resulted in minimal increased risk of an accident, it was allocated a score 
of 0.5. If another road user was forced to evasively act, or if the behaviour 
or event increased the risk of an accident, causing distress or discomfort, 
it was allocated a score of 1. These scores were tallied, providing error 
scores attributable to inattention, impatience, and aggression.  
Definitions of the three types of driving errors were consistent with 
those of the relevant scales of the Manchester Driver Behaviour 
Questionnaire (DBQ) (Reason, Manstead, Stradling, Baxter, & Campbell, 
1990). Inattentive errors reflected lapses, impatient or impulsive errors 
reflected violations, and aggressive errors, reflected items on the 
aggressive violations scale of the DBQ (Lawton, Parker, Manstead, & 
Stradling, 1997; Reason et al., 1990). While impatient and aggressive 
driving errors; much like violations and aggressive violations, arise with 
motivation, inattentive driving errors are defined by an absence of wilful 
intent. 
An inattentive error occurred when a lapse in driver attention 
resulted in failure to safely perform a driving behaviour. Lapses involved 
minor failures of attention or memory, and occurred when a driver 
became distracted by an overt secondary task such as using a cell phone 
or adjusting the dials of a radio, or in the context of inattention or 
daydreaming, signalled by a gaze fixated in or outside the car, toward 
pedestrians, animals, or billboards etc. (Reason et al., 1990). Distraction 
from the forward roadway may manifest errors such as failure to signal, 
give way at a stop sign, or as delayed recognition of and response to 
hazards in the driving environment. 
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Impatient errors include deliberate violations of safe driving 
behaviours. They involve reckless driving acts that lack a malicious or 
aggressive aim. Activities such as speeding, and weaving in and out of 
lanes due to boredom might indicate impatient driving errors (Reason et 
al., 1990). Aggressive behaviours however are defined by their 
interpersonally aggressive and typically hostile nature (Lawton et al., 
1997). Frustration at other road users can lead to anger, and selfish or 
competitive aggressive behaviours designed to achieve personal driving 
goals. Such behaviours might include cutting off other drivers, running 
red lights, failing to yield, or tailgating (Reason et al.). 
Inter Rater Reliability 
Scoring was initially conducted by an in car observer who was not 
blinded to condition. Two independent observers who were blinded to 
condition, later scored the video footage of 5 randomly selected 
participants from each group as they completed 5 driving tasks. The blind 
observers were provided an operationally defined scoring guide (see 
Appendix E), video footage for the 15 participants, and the times at which 
participants performed each of the tasks. They were instructed to read 
carefully over the scoring guide, and to replay the video footage as many 
times as necessary to score all of the items. No further instruction was 
given. Cronbach’s alpha was calculated using this data to determine 
agreement between observers. There was substantial agreement between 
the blinded observers and the in car observer, α = .895 (95% CI = .841 to 
.931), p < .001. 
Self-Report Measures 
Self-reported data relating to engagement in risky driving 
behaviours and driving history, symptoms and behaviours of ADHD in 
adulthood, and absent-mindedness in daily living were collected.  
Manchester Driver Behaviour Questionnaire (DBQ). 
Developed as an inventory of driving behaviours associated with 
adverse outcomes on the road, the DBQ (Reason et al., 1990) is now one 
of the most extensively employed self-report measures of risky driving 
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behaviour (Lajunen, Parker & Summala, 2004). A four-factor model was 
utilised in the present study yielding a total score, and four scale scores 
capturing errors, lapses of attention and memory, violations, and 
aggressive violations. Errors describe unsafe behaviours that are 
definitively unplanned (Reason et al., 1990). Aggressive violations are 
distinguishable by their directed aggressive and hostile nature, and might 
include repeated honking of a horn, or the heated pursuit of another 
motorist (Lawton et al., 1997). Violations however are intentional 
digressions from safe driving practice that do not have an aggressive aim; 
such as exceeding the speed limit or failing to stop at a red light (Lawton 
et al., 1997). The DBQ was presented to participants in a single-page 
format with additional questions regarding licensure, average weekly 
mileage, history of infringements and motor vehicle collisions. 
Participants indicated on a six-point Likert-type scale how regularly each 
of the 28 items describing unsafe driving behaviours had happened to 
them in the past year. A higher score indicates more frequent 
engagement in the relevant risky driving behaviour. The DBQ has 
demonstrated moderate to high levels of internal consistency (.65 to .79) 
and test-retest reliability (r = .65 to .75) at 6-month follow up (Harrison, 
2011). 
Conners’ Adult ADHD Rating Scale. 
Designed for use amongst an adult population, the Conners’ Adult 
ADHD Rating Scales (CAARS) assess archetypal problem behaviours 
associated with ADHD in adulthood (Conners, Erhardt, & Sparrow, 1999). 
Participants completed the long, self-reported version of the CAARS 
(CAARS–S:L), comprising 66 items scored on a Likert-type scale ranging 
from 0 (Not at all, never) to 3 (Very much, frequently). Four scales 
describing problems of inattention and memory, hyperactivity, impulsivity, 
and self-concept, 3 DSM-IV (American Psychological Association, 1994) 
ADHD symptom subscales, a total ADHD symptom scale, and an 
inconsistency index were obtained and used for data analysis (Conners et 
al., 1999). Higher scores indicate higher symptom severity. Test-retest 
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reliability scores for the clinical scales of the CAARS–S: L range from r = 
.88 to r = .91 at one month follow up, indicating strong short-term stability 
(Conners et al.). Internal consistency varies between .49 and .91, 
depending on the scale, gender, and age group of the standardised 
sample.  
Cognitive Failures Questionnaire. 
Tendency to commit failures of memory, perception, and motor 
function was measured using the Cognitive Failures Questionnaire (CFQ; 
Broadbent, Cooper, FitzGerald, & Parkes, 1982). Participants were 
instructed to indicate how frequently they had experienced each of the 25 
minor mistakes in the past 6 months on a 5-point Likert-type scale 
(Broadbent et al., 1982). CFQ total scores were calculated. Higher scores 
indicate more frequent failures of cognition. The psychometric properties 
of the CFQ have proven moderately robust, supporting its utility in 
research and moderate stability over time (Bridger, Johnsen & Brasher, 
2013). Internal consistency is high, ranging from .85 to .89, and overall 
test-retest reliability ranging from r = .71 and r = .82 at 2 year follow-up 
(Bridger et al., 2013; Broadbent et al.).  
Procedure 
All participants underwent the same testing procedure. Potential 
participants who expressed an interest in the study from the noticeboards 
or emails were provided a Research Information Sheet (see Appendix F) 
outlining the purpose and background of the research. Participants chose 
a meeting time, and whether they preferred to meet at a café, another 
public area, or in their own homes. Participants from the Hamilton area 
were also invited to meet at an office on campus at the University of 
Waikato. On the day of testing, participants were first briefed on the 
background and procedure of the research. Details related to the use of a 
video camera during the driving segment of the test were provided. 
Participants were encouraged to ask questions before reviewing and 
signing both copies of the Research Consent Form (see Appendix G). 
They were then provided several self-report questionnaires relating to 
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risky driving behaviours and driving history, tendency to commit cognitive 
failures, and ADHD symptomology.  
The driving element of the study was assessed in the participant’s 
own vehicle to minimise the potential or any errors attributable to 
unfamiliarity. The researcher first ensured a current registration and 
warrant of fitness was displayed before mounting an in-car camera and 
being seated in the passenger’s seat. The in-car camera recorded video 
footage throughout the on road assessment (see Figure 1). 
!
!
Figure 1.      Field of view captured by the in car video camera system. 
!
Participants were instructed to drive as they normally would whilst 
directions were provided by the researcher. Each direction was clearly 
stated with sufficient time for preparatory behaviours such as head 
checks and signalling. Participants first navigated a 5-minute safety route 
serving as a preliminary test of the basic driving skills required to safely 
complete the on-road task. Drivers who passed the safety check 
continued to navigate the assessed route as instructed. Those unable to 
demonstrate such skills however were to return to the start point, 
concluding the assessed component of the session. All participants 
successfully passed the preliminary driving safety check, and were able 
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to proceed onto the assessed part of the drive. Performance was scored 
initially during the drive by the accompanying observer. On completion of 
the on-road task, all participants were given a $20 MTA voucher (for fuel 
and other goods) as a thank you, and to reimburse fuel costs. 
Statistical Analysis 
Raw data were first inspected for outliers using the boxplot 
function. The data of one control participant was excluded from the 
analyses, as scores across a number of self and observer reported 
measures were found to fall more than 3 SD outside the mean for the 
control group. No further outliers were identified. The first section of the 
results presents group demographic and clinical characteristics; 
compared using Pearson’s chi-square for categorical variables, and one-
way analysis of variance (ANOVA) for scale variables.  
Group differences in driving performance and driving errors, history 
of infringements and crashes, and engagement in risky driving behaviours 
were investigated using one-way ANOVA. Post hoc testing was 
conducted using Tukey’s HSD, or the Games-Howell procedure when the 
homogeneity of variance assumption was violated. A logistic regression 
was conducted to evaluate the effect of group on lifetime involvement in 
multiple crashes.  
Several measures were standardised for comparison by 
subtracting the overall mean and dividing by the standard deviation. 
Bivariate correlations were calculated between standardised self- and 
observer reported measures, and discrepancies compared using one-way 
ANOVA. To compare the effect of environmental demand and arousal 
across the groups, standardised measures of performance within each 
driving environment were compared using one-way ANOVA. Composite 
measures of impaired performance were also calculated by subtracting 
each participant’s inattentive, impatient, and aggressive error score within 
each environment from their overall performance in that environment. A 
3X4 MANOVA was then used to examine group differences across the 
four driving environments. Multivariate effects of group and environment 
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were calculated using Wilks’ statistic.  
Within-group influences of on road performance were investigated 
using independent t-tests for vehicle transmission, and separate one-way 
ANOVAs for diagnostic type. To explore the effect of aggression on 
performance outcomes, group bivariate correlations were calculated.  
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Results 
The present study aimed firstly to explore differences between 
medicated ADHD, unmedicated ADHD, and control group drivers across 
self and observer reported measures of driving performance and 
behaviour. The congruency of self and observer-report was investigated. 
Group differences in specific measures of on road performance are then 
described. Finally, the influences of environmental demand, aggression, 
and diagnostic subtype on driving outcomes are explored.  
Group Characteristics 
Group demographic and driving characteristics are presented in 
Table 2. Gender composition was found to be unequal between groups, 
with the control group composed of only 35% males, compared to 47% 
of the medicated ADHD group, and 75% of the unmedicated ADHD 
group; χ2(2) = 12.96, p = .002. No further differences in baseline 
demographic or driving characteristics were found. 
%
Group differences in absent-mindedness in daily living (CFQ), 
ADHD symptomology (CAARS), and diagnosed health conditions are 
presented in Table 3. A significant effect of group was shown for absent-
mindedness in daily living, as measured by CFQ total score. Post hoc 
analysis revealed that both medicated (p < .001) and unmedicated (p < 
.001) ADHD group CFQ scores were significantly higher than those of 
control participants.  
Table 1 
Pharmacotherapy of ADHD and its use in New Zealand 
 
Medication Drug name Form Use in New Zealand Duration 
Mixed Amphetamine Salts  
(MAS-XR) 
Adderall 
 
Dexamphetamine, Levoamphetamine 
extended release 
Not available  
 
8 – 12 hours 
 
Dexamfetamine (DEX) 
 
PSM/  
Dexedrine 
Dexamphetamine sulphate 
short acting 
Fully subsidised 
 
4 – 6 hours 
 
Methylphenidate (MPH) 
 
Rubifen IR a 
 
Methylphenidate Hydrochloride 
immediate-release 
Fully subsidised 
 
3 – 4 hours 
 
 Rubifen SR  
Methylphenidate Hydrochloride  
sustained-release 
Fully subsidised 
 
4 – 8 hours 
 
 Ritalin IR a Methylphenidate Hydrochloride immediate-release 
PHARMAC funding ceased  
Now Rubifen SR 
3 – 4 hours 
 
 Ritalin SR Methylphenidate Hydrochloride intermediate acting 
Fully subsidised 
 
4 – 8 hours 
 
 Ritalin LA Methylphenidate Hydrochloride  modified, intermediate-release  
Fully subsidised 
 
8 – 10 hours 
 
Methylphenidate (MPH) 
Extended-release 
Concerta XR 
 
Methylphenidate Hydrochloride  
osmotic-controlled release 
Fully subsidised 
 
 
10 – 12 hours 
 
 
Methylphenidate  
Transdermal (MTS) patch 
Daytrana patch 
 
Methylphenidate Hy rochloride 
transdermal-release system 
Not available 
 
10 – 12 hours 
 
Lisdexamfetamine (LDX) Vyvanse Lisdexamfetamine  Not available 10 – 12 hours 
Atomoxetine (ATX) Strattera b Atomoxetine Second line treatment 24 hours 
Note. a Considered bioequivalent. b  Non-stimulant. 
 
 
Table 2 
Group demographic and driving characteristics 
 Age Licensed driving experience  
Average weekly 
mileage  Gender License type Transmission  
  Male Restricted Full Automatic Manual  
Control 30.24 (3.31) 146.41(36.36) 210.00 (34.89) 6 (35%) 2 (12%) 15 (88%) 13 (72%) 4 (28%) 
Medicated ADHD 38.73 (3.52) 197.07 (43.99) 206.00 (68.04) 7 (47%) 2 (13%) 13 (87%) 9 (60%) 6 (40%) 
Unmedicated ADHD 38.67 (3.83) 206.67 (51.76) 223.33 (41.31) 9 (75%) 0 (0%) 12 (100%) 6 (50%) 6 (50%) 
Total 35.43 (2.09) 180.11 (24.67) 212.27 (28.44) 22 (49%) 4 (9%) 40 (91%) 28 (59%) 16 (41%) 
Note. Mean (SE) or n (%) ! !
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Mean ADHD symptom scores fell within the normal percentile 
range across all subscales of the CAARS for the control group. Both 
medicated and unmedicated ADHD group t-score means were indicative 
of severe ADHD symptomology, falling above the 98th percentile for 
DSM-IV ADHD Symptoms Total. Both ADHD groups reported significantly 
higher symptom scores than controls across all subscales of the CAARS 
(p < .05). No differences were found between mean Subscale scores 
reported by the medicated and unmedicated ADHD groups. The two 
ADHD groups were made up of a similar proportion of predominantly 
inattentive, predominantly hyperactive-impulsive, and combined 
subtypes. Diagnostic subtype was supported by symptom scores above 
the 98th percentile on the relevant subscales of the CAARS.  %
!
 
Table 3 
Group clinical characteristics 
 
Control 
(n = 17) 
Medicated ADHD 
(n = 15) 
   Unmedicated ADHD 
(n = 12) 
F (2, 41) p ηp² 
CFQ 37.12!(3.42) 67.10 (3.51) 62.75 (4.18) 26.62*** < .001 .737 
CAARS-S: L       
Inattention/ Memory 50.82!(2.41) 73.60!(2.47) 71.83!(3.35) 26.63*** < .001 .737 
Hyperactivity/ Restlessness 46.41!(1.61) 59.00!(4.20) 64.83!(2.95) 10.33*** < .001 .550 
Impulsivity/ Emotional Lability 47.76 (1.92) 65.60!(5.00) 64.58!(3.57) 8.89** < .01 .518 
Problems with Self Concept 48.94 (2.55) 63.00 (4.59) 57.42 (3.77) 4.87* <.050 .391 
DSM-IV Inattentive 52.64!(2.46) 75.87 (4.94) 79.67 (2.99) 18.39*** < .001 .669 
DSM-IV Hyperactive-Impulsive 44.29 (2.48) 65.00 (4.86) 74.33 (3.51) 17.49*** < .001 .659 
DSM-IV ADHD Symptoms Total 48.53 (2.49) 75.80 (3.82) 81.67 ((2.30) 35.07** < .001 .796 
ADHD Index 47.88 (2.02) 68.53 (3.94) 69.67 (3.37) 16.91*** < .001 .652 
Comorbid conditions       
Total 6 (35.29%) 7 (46.67%) 9 (75.00%) 2.357 NS .241 
Depression 1 (5.88%) 6 (40.00%) 8 (66.67%) 7.691** .001 .483 
Anxiety 1 (5.88%) 1 (6.67%) 5 (41.67%) 7.027** .002 .464 
  
Medicated ADHD 
(n = 15) 
    Unmedicated ADHD 
(n = 12) 
t(25) p 
 
Diagnostic type       
Inattentive  8 (53.3%) 4 (33.3%) 1.51 NS  
Hyperactive-Impulsive  2 (13.3%) 4 (33.3%) 6.18 NS  
Combined  
 
5 (33.3%) 4 (33.3%) 0.00 NS  
Note. Mean (SE) or n(%) 
*p < 0.05. **p <0.01.***p <0.001. !!
Table 6 
Self-reported engagement in risky driving behaviours by group 
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Errors 1.15 (0.14) 2.29 (0.26) 1.83 (0.22) 8.02** .001 .496 
Lapses 0.55 (0.06) 1.08 (0.16) 0.92 (0.16) 4.71* .015 .384 
Violations 1.51 (0.19) 1.82 (0.33) 2.13 (0.24) 1.33 .276 .123 
Aggressive Violations 0.86 (0.11) 1.64 (0.29) 1.72 (0.29) 4.28* .021 .364 
DBQ Total Score 27.06 (2.52) 45.93 (5.40) 44.50 (5.21) 5.97** .005 .433 
Note. Mean (SE).  
*p < 0.05. **p <0.01. !
Table 7 
Discrepancy between self- and observer reported measures of risky driving behaviour by group 
Observer Self-report Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Inattention Errors -0.27 (0.19) 0.92 (0.20) -0.84 0.40) 11.747*** < .001 .582 
Impatience Violations 0.12 (0.22) 0.42 (0.28) -0.75 (0.29) 4.610* .016 .383 
Aggression Aggressive Violations -0.47 (0.20) 0.62 (0.30) -0.11 (0.53) 3.556* .038 .329 
Note. Mean (SE).  
*p < 0.05. **p <0.01. ***p <0.001. 
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A total of 22 (50%) participants reported having been diagnosed 
with and/or treated for a health condition other than ADHD. The 
prevalence of mental health conditions was found to differ significantly 
between groups. A higher prevalence of depression compared to controls 
(p = .001), and of anxiety compared to controls (p = .005), and medicated 
ADHD participants (p = .007) was reported by the unmedicated ADHD 
group. Medicated ADHD drivers were also more likely to have been 
diagnosed with depression than were controls (p = .046). 
Overall Driving Performance 
Table 4 presents group differences in overall driving performance 
and observer reported engagement in errors attributable to inattention, 
impatience, and aggression. Significant main effects of group were 
obtained for overall driving performance, engagement in inattentive, 
impatient, and total driving errors. Post hoc analysis revealed no 
significant differences in overall driving performance or engagement in 
driving errors between medicated ADHD and control group drivers.  
 
 
 
Overall driving performance was significantly worse amongst 
unmedicated compared to medicated ADHD drivers (p = .025). 
Unmedicated ADHD drivers engaged in significantly more inattentive (p = 
.028), impatient (p = .002), and total driving errors (p = .001) compared to 
medicated ADHD drivers. A trend for more aggressive errors was also 
Table 9!
Pearson correlations between ADHD symptom severity (CAARS) and measures of on road performance 
 Control 
 Medicated ADHD  Unmedicated ADHD 
 Inattentive Hyperactive  
 Inattentive Hyperactive   Inattentive Hyperactive 
Observation -.60* -.32  -.33 -.42  .17 -.21 
Following Distance -.41 -.57*  -.18 -.37  .58* -.65* 
Signalling -.55* -.02  -.00 -.51*  -.03 -.44 
Gap Selection .06 -.17  .64** .54*  .40 -.39 
Hazard Detection -.14 .02  .62* .44*  .50 -.17 
Hazard Response -.71** -.27  .05 .34  -.17 -.36 
Speed -.64** -.48*  -.26 -.63*  .42 -.54* 
Overall Performance -.74*** -.52*  .28 -.01  .38 -.50* 
Inattentive errors .34 .43  .03 -.54*  .12 .73** 
Impatient errors .34 -.00  .36 .68**  -.56* .56* 
Aggressive errors -.07 .22  .08 .36  -.71** .36 
         
Note. Pearson’s r.  Inattentive and Hyperactive/ Impulsive Subscales of the CAARS-S: L.  
*p < 0.05. **p < 0.01. !!!
Table 5 
Logistic regression of the ffects of gr up, age, and driving experience on involvement in multiple crashes 
     
95% CI  
Step 1 B (SE) Wald df p Lower Odds Ratio Upper 
Group  6.42 2 .040    
Medicated ADHD (1) 2.72  (1.18) 5.35* 1 .021 1.52 15.19 152.22 
Unmedicated ADHD (2) 2.94  (1.20) 5.97* 1 .015 1.79 18.96 200.81 
Age 0.59  (0.43) 1.86 1 .173 0.77 1.80 4.18 
Experience -0.00  (0.00) 0.69 1 .406 0.99 1.00 1.00 
Constant -3.04  (1.15) 6.94** 1 .008  0.05  
        
Note. CI = confidence interval.   
R2 = .290 (Cox & Snell), .397 (Nagelkerke). 
*p < 0.05. **p <0.01. !!!
Table 4 
Overall driving performance and error scores by group 
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Overall performance 88.10 (1.91) 91.84 (1.32) 83.26 (3.19) 3.721* .033 .332 
Inattentive errors 1.47 (0.26) 1.50 (0.29) 2.83 (0.49) 4.797* .013 .384 
Impatient errors 0.71 (0.27) 0.67 (0.24) 2.92 (0.70) 9.095*** < .001 .519 
Aggressive errors 0.47 (0.26) 0.23 (0.11) 1.42 (0.70) 2.473 .097 .251 
Total errors 2.65 (0.49) 2.40 (0.47) 7.17 (1.41) 10.301*** < .001 .545 
       
Note. Mean (SE) 
*p < 0.05. **p < .01. ***p < .001. 
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revealed (p = .097). Compared to controls, unmedicated ADHD drivers 
committed significantly more errors attributable to inattention (p = .020), 
and impatience (p = .001), as well as more total driving errors (p = .001). 
Self-Report Measures 
Driving history. 
Self-reported driving infringement data from the past year, and 
lifetime involvement in crashes and at fault crashes were obtained. Just 
one unmedicated ADHD participant reported receiving a driving 
infringement (8.4%), compared to 7 control (41.2%) and 6 medicated 
ADHD (40.0%) drivers. Group differences in self-reported infringement 
history were not found to be significant.  
Self-reported involvement in crashes was found to differ 
significantly between groups; F(2, 39) = 7.021, p = .002, ηp² = .549. 
Compared to controls (M = 0.69, SE = 0.15), both medicated (p = .007) 
and unmedicated ADHD (p = .008) drivers were more likely to have been 
involved in a crash. No differences in self-reported crash involvement 
were found between the medicated (M = 2.50, SE = 0.95) and 
unmedicated (M = 2.33, SE = 0.62) ADHD groups. Compared to controls 
(M = 0.38, SE = 0.13), medicated (M = 0.79, SE = 0.30) and unmedicated 
ADHD (M = 1.25, SE = 0.48) drivers also reported involvement in more 
crashes in which they were found at fault, however these differences did 
not reach statistical significance. 
Lifetime involvement in multiple crashes was then investigated. 
Just 5.8% of control group drivers reported having been involved in 
multiple crashes, compared to 20.0% of medicated, and 16.7% of 
unmedicated ADHD participants. A logistic regression of the effects of 
group, age, and licensed driving experience was conducted (see Table 5). 
The model explained 39.7% of the variance in reported involvement in 
multiple crashes, and correctly classified 70.5% of cases. Compared to 
controls, medicated ADHD drivers were 15.19 times more likely; and 
unmedicated ADHD drivers 18.96 times more likely, to report involvement 
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in multiple collisions. Age and driving experience did not significantly 
influence the likelihood of being involved in multiple collisions.  
 
Risky driving behaviour.% 
Table 6 presents group differences in self-reported engagement in 
risky driving behaviours. DBQ total score, and four scale scores 
describing driver lapses, errors, violations, and aggressive violations were 
obtained. Scales scores represent an average of the relevant items. Item 
15 was omitted amongst participants who drove a vehicle with an 
automatic transmission, as it describes a driving error relevant only for 
manual drivers. A significant effect of group was obtained for driving 
errors, lapses, aggressive violations, and DBQ Total score. Post hoc 
analysis revealed no significant differences between the medicated and 
unmedicated ADHD groups. Compared to the control group, medicated 
ADHD drivers reported engaging in significantly more errors (p = .001), 
lapses (p = .013), aggressive violations (p = .048), and DBQ Total risky 
driving behaviours (p = .009). Compared to controls, unmedicated ADHD 
drivers also reported engaging in significantly more aggressive violations 
(p = .039), and total risky driving behaviours (p = .025).  
 
Table 9!
Pearson correlations between ADHD symptom severity (CAARS) and measures of on road performance 
 Control 
 Medicated ADHD  Unmedicated ADHD 
 Inattentive Hyperactive  
 Inattentive Hyperactive   Inattentive Hyperactive 
Observation -.60* -.32  -.33 -.42  .17 -.21 
Following Distance -.41 -.57*  -.18 -.37  .58* -.65* 
Signalling -.55* -.02  -.00 -.51*  -.03 -.44 
Gap Selection .06 -.17  .64** .54*  .40 -.39 
Hazard Detection -.14 .02  .62* .44*  .50 -.17 
Hazard Response -.71** -.27  .05 .34  -.17 -.36 
Speed -.64** -.48*  -.26 -.63*  .42 -.54* 
Overall Performance -.74*** -.52*  .28 -.01  .38 -.50* 
Inattentive errors .34 .43  .03 -.54*  .12 .73** 
Impatient errors .34 -.00  .36 .68**  -.56* .56* 
Aggressive errors -.07 .22  .08 .36  -.71** .36 
         
Note. Pearson’s r.  Inattentive and Hyperactive/ Impulsive Subscales of the CAARS-S: L.  
*p < 0.05. **p < 0.01. !!!
Table 5 
Logistic regression of the effects of group, age, and driving experience on involvement in multiple crashes 
     
95% CI  
Step 1 B (SE) Wald df p Lower Odds Ratio Upper 
Group  6.42 2 .040    
Medicated ADHD (1) 2.72  (1.18) 5.35* 1 .021 1.52 15.19 152.22 
Unmedicated ADHD (2) 2.94  (1.20) 5.97* 1 .015 1.79 18.96 200.81 
Age 0.59  (0.43) 1.86 1 .173 0.77 1.80 4.18 
Experience -0.00  (0.00) 0.69 1 .406 0.99 1.00 1.00 
Constant -3.04  (1.15) 6.94** 1 .008  0.05  
        
Note. CI = confidence interval.   
R2 = .290 (Cox & Snell), .397 (Nagelkerke). 
*p < 0.05. **p <0.01. !!!
Table 4 
Overall driving performance and error scores by group 
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(  = 12) F(2, 41) p ηp² 
Overall performance 88.10 (1.91) 91.84 (1.32) 83.26 (3.19) 3.721* .033 .332 
Inattentive errors 1.47 (0.26) 1.50 (0.29) 2.83 (0.49) 4.797* .013 .384 
Impatient errors 0.71 (0.27) 0.67 (0.24) 2.92 (0.70) 9.095*** < .001 .519 
Aggressive errors 0.47 (0.26) 0.23 (0.11) 1.42 (0.70) 2.473 .097 .251 
Total errors 2.65 (0.49) 2.40 (0.47) 7.17 (1.41) 10.301*** < .001 .545 
       
Note. Mean (SE) 
*p < 0.05. **p < .01. ***p < .001. 
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Accuracy of Self-Report 
The relationship between self- and observer-reported measures 
describing inattentive, impatient, and aggressive driving behaviours were 
investigated. Scores were first standardised by subtracting the overall 
mean and dividing by the standard deviation. Error and lapse scale 
scores were contrasted with observer-reported inattentive errors. 
Violation scale scores were contrasted with observer-reported impatient 
errors, and scores on the aggressive violations scale were contrasted 
with observer-reported impatient and aggressive errors. 
Group bivariate correlations between self- and observer-reports 
were calculated. Self-reported errors were found to correlate significantly 
with observer-reported inattentive errors amongst control (r = .48, p = 
.050), and medicated ADHD (r = .67, p = .007) drivers. Self-reported 
violations (r = .64, p = .010) and aggressive violations (r = 76, p = .001) 
correlated significantly with observer reported impatient errors amongst 
the medicated ADHD group. Observed impatient errors were also found 
to correlate with unmedicated ADHD group self-reports of engagement in 
violations (r = .61, p = .037), and aggressive violations (r = .66, p = .021). 
Self- and observer reported impatient and aggressive driving behaviours 
were not found to correlate amongst control group drivers. 
Figure 2 depicts the relationship between standardised self-and 
observer-report measures by group. Despite underreporting of aggressive 
driving behaviours, self- and observer-reports appeared to be most 
Table 3 
Group clinical characteristics 
 
Control 
(n = 17) 
Medicated ADHD 
(n = 15) 
   Unmedicated ADHD 
(n = 12) 
F (2, 41) p ηp² 
CFQ 37.12!(3.42) 67.10 (3.51) 62.75 (4.18) 26.62*** < .001 .737 
CAARS-S: L       
Inattention/ Memory 50.82!(2.41) 73.60!(2.47) 71.83!(3.35) 26.63*** < .001 .737 
Hyperactivity/ Restlessness 46.41!(1.61) 59.00!(4.20) 64.83!(2.95) 10.33*** < .001 .550 
Impulsivity/ Emotional Lability 47.76 (1.92) 65.60!(5.00) 64.58!(3.57) 8.89** < .01 .518 
Problems with Self Concept 48.94 (2.55) 63.00 (4.59) 57.42 (3.77) 4.87* <.050 .391 
DSM-IV Inattentive 52.64!(2.46) 75.87 (4.94) 79.67 (2.99) 18.39*** < .001 .669 
DSM-IV Hyperactive-Impulsive 44.29 (2.48) 65.00 (4.86) 74.33 (3.51) 17.49*** < .001 .659 
DSM-IV ADHD Symptoms Total 48.53 (2.49) 75.80 (3.82) 81.67 ((2.30) 35.07** < .001 .796 
ADHD Index 47.88 (2.02) 68.53 (3.94) 69.67 (3.37) 16.91*** < .001 .652 
Comorbid conditions       
Total 6 (35.29%) 7 (46.67%) 9 (75.00%) 2.357 NS .241 
Depression 1 (5.88%) 6 (40.00%) 8 (66.67%) 7.691** .001 .483 
Anxiety 1 (5.88%) 1 (6.67%) 5 (41.67%) 7.027** .002 .464 
  
Medicated ADHD 
(n = 15) 
    Unmedicated ADHD 
(n = 12) 
t(25) p 
 
Diagnostic type       
Inattentive  8 (53.3%) 4 (33.3%) 1.51 NS  
Hyperactive-Impulsive  2 (13.3%) 4 (33.3%) 6.18 NS  
Combined  
 
5 (33.3%) 4 (33.3%) 0.00 NS  
Note. Mean (SE) or n(%) 
*p < 0.05. **p <0.01.***p <0.001. !!
Table 6 
Self-reported engagement in risky driving behaviours by group 
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Errors 1.15 (0.14) 2.29 (0.26) 1.83 (0.22) 8.02** .001 .496 
Lapses 0.55 (0.06) 1.08 (0.16) 0.92 (0.16) 4.71* .015 .384 
Violations 1.51 (0.19) 1.82 (0.33) 2.13 (0.24) 1.33 .276 .123 
Aggressive Violations 0.86 (0.11) 1.64 (0.29) 1.72 (0.29) 4.28* .021 .364 
DBQ Total Score 27.06 (2.52) 45.93 (5.40) 44.50 (5.21) 5.97** .005 .433 
Note. Mean (SE).  
*p < 0.05. **p <0.01. !
Table 7 
Discrepancy between self- and observer reported measures of risky driving behaviour by group 
Observer Self-report Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Inattention Errors -0.27 (0.19) 0.92 (0.20) -0.84 0.40) 11.747*** < .001 .582 
Impatience Violations 0.12 (0.22) 0.42 (0.28) -0.75 (0.29) 4.610* .016 .383 
Aggression Aggressive Violations -0.47 (0.20) 0.62 (0.30) -0.11 (0.53) 3.556* .038 .329 
Note. Mean (SE).  
*p < 0.05. **p <0.01. ***p <0.001. 
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congruent amongst the control group. While unmedicated ADHD drivers 
largely underreported their engagement in inattentive and impatient 
driving behaviours, medicated ADHD drivers consistently overestimated 
their engagement in inattentive, impatient, and aggressive driving 
behaviours compared to that observed on the road.  %
%
 
To establish the significance of these group differences, 
discrepancy scores were calculated by subtracting self- from observer-
reported measures (see Table 7). Negative values therefore indicate 
underreporting of risky driving compared to that observed on the road. 
Values close to zero indicate consensus of self-and observer reports, and 
positive values indicate over-reporting of risky driving compared to that 
observed on the road. 
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Figure 2. Self- and observer-reported engagement in inattentive, impatient, and aggressive
driving behaviours by group.
Medicated and unmedicated ADHD group driving skills by vehicle transmission.Figure 3.
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Significant differences in the congruency of self- and observer-
reports were revealed across measures. Medicated ADHD drivers over 
reported their engagement in inattentive driving behaviours relative to 
control (p = .003) and unmedicated ADHD drivers (p < .001). The 
congruency of self- and observer reported impatient behaviours differed 
significantly between the ADHD driver groups (p = .014). While medicated 
ADHD drivers largely over reported engagement in impatient behaviours, 
underreporting was revealed amongst the unmedicated group relative to 
that observed on the road. Medicated ADHD drivers also over reported 
their engagement in aggressive driving compared to controls (p = .007). 
Congruence was highest amongst unmedicated ADHD drivers for 
aggressive driving.  %
 
 
Driving Skills 
Group differences in specific measures of on road driving skills are 
presented in Table 8. Significant main effects of group were obtained for 
gap selection, hazard detection, hazard response, and speed. Post hoc 
analysis revealed that the medicated ADHD group demonstrated better 
observation skills (p = .047), selected safer gaps in traffic (p = .017), and 
drove at safer speeds (p = .028) compared to unmedicated ADHD drivers. 
Control group drivers maintained significantly safer speeds than 
unmedicated ADHD drivers (p = .036). A non-significant trend for more 
Table 3 
Group clinical characteristics 
 
Control 
(n = 17) 
Medicated ADHD 
(n = 15) 
   Unmedicated ADHD 
(n = 12) 
F (2, 41) p ηp² 
CFQ 37.12!(3.42) 67.10 (3.51) 62.75 (4.18) 26.62*** < .001 .737 
CAARS-S: L       
Inattention/ Memory 50.82!(2.41) 73.60!(2.47) 71.83!(3.35) 26.63*** < .001 .737 
Hyperactivity/ Restlessness 46.41!(1.61) 59.00!(4.20) 64.83!(2.95) 10.33*** < .001 .550 
Impulsivity/ Emotional Lability 47.76 (1.92) 65.60!(5.00) 64.58!(3.57) 8.89** < .01 .518 
Problems with Self Concept 48.94 (2.55) 63.00 (4.59) 57.42 (3.77) 4.87* <.050 .391 
DSM-IV Inattentive 52.64!(2.46) 75.87 (4.94) 79.67 (2.99) 18.39*** < .001 .669 
DSM-IV Hyperactive-Impulsive 44.29 (2.48) 65.00 (4.86) 74.33 (3.51) 17.49*** < .001 .659 
DSM-IV ADHD Symptoms Total 48.53 (2.49) 75.80 (3.82) 81.67 ((2.30) 35.07** < .001 .796 
ADHD Index 47.88 (2.02) 68.53 (3.94) 69.67 (3.37) 16.91*** < .001 .652 
Comorbid conditions       
Total 6 (35.29%) 7 (46.67%) 9 (75.00%) 2.357 NS .241 
Depression 1 (5.88%) 6 (40.00%) 8 (66.67%) 7.691** .001 .483 
Anxiety 1 (5.88%) 1 (6.67%) 5 (41.67%) 7.027** .002 .464 
  
Medicated ADHD 
(n = 15) 
    Unmedicated ADHD 
(n = 12) 
t(25) p 
 
Diagnostic type       
Inattentive  8 (53.3%) 4 (33.3%) 1.51 NS  
Hyperactive-Impulsive  2 (13.3%) 4 (33.3%) 6.18 NS  
Combined  
 
5 (33.3%) 4 (33.3%) 0.00 NS  
Note. Mean (SE) or n(%) 
*p < 0.05. **p <0.01.***p <0.001. !!
Table 6 
Self-reported engagement in risky driving behaviours by group 
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Errors 1.15 (0.14) 2.29 (0.26) 1.83 (0.22) 8.02** .001 .496 
Lapses 0.55 (0.06) 1.08 (0.16) 0.92 (0.16) 4.71* .015 .384 
Violations 1.51 (0.19) 1.82 (0.33) 2.13 (0.24) 1.33 .276 .123 
Aggressive Violations 0.86 (0.11) 1.64 (0.29) 1.72 (0.29) 4.28* .021 .364 
DBQ Total Score 27.06 (2.52) 45.93 (5.40) 44.50 (5.21) 5.97** .005 .433 
Note. Mean (SE).  
*p < 0.05. **p <0.01. !
Table 7 
Discrepancy between self- and observer reported measures of risky driving behaviour by group 
Observer Self-report Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Inattention Errors -0.27 (0.19) 0.92 (0.20) -0.84 0.40) 11.747*** < .001 .582 
Impatience Violations 0.12 (0.22) 0.42 (0.28) -0.75 (0.29) 4.610* .016 .383 
Aggression Aggressive Violations -0.47 (0.20) 0.62 (0.30) -0.11 (0.53) 3.556* .038 .329 
Note. Mean (SE).  
*p < 0.05. **p <0.01. ***p <0.001. 
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appropriate use of indicators was also revealed amongst controls 
compared to unmedicated ADHD drivers (p = .083). 
 
While controls tended to identify hazards in the driving 
environment more effectively than unmedicated ADHD drivers (p = .070), 
responses to those hazards were more likely to be less effective. 
Similarly, while medicated ADHD and control group drivers demonstrated 
similar hazard detection skills, medicated ADHD drivers likely to respond 
more effectively than controls (p = .034). No further differences between 
the medicated ADHD and control groups were revealed. 
Demand 
 Transmission. 
To establish the effect of vehicle transmission on sustained 
attention and performance, independent t-tests were conducted for each 
group with transmission as the independent variable. No significant effect 
was revealed amongst the control group. Figure 3 compares the mean 
performance of automatic and manual drivers amongst the medicated 
and unmedicated ADHD groups.  
 
!
Table 8!
On road driving skills by group!
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Observation 91.80 (1.99) 94.26 (1.49) 86.69 (2.81) 3.116 .056 .303 
Comfort 82.90 (4.10) 90.91 (1.31) 78.60 (5.23) 2.533 .092 .261 
Following Distance 92.53 (1.91) 95.44 (2.41) 85.55 (5.60) 2.115 .134 .225 
Signalling 92.35 (2.72) 85.49 (3.31) 81.37 (4.14) 2.542 .092 .262 
Gap selection 94.34 (1.40) 97.16 (0.98) 87.85 (3.87) 4.326* .020 .370 
Hazard detection 94.32 (2.26) 94.06 (2.33) 86.08 (3.11) 3.166* .050 .306 
Hazard response 78.54 (5.24) 94.35 (2.61) 85.80 (4.57) 3.440* .042 .322 
Speed 86.03 (2.28) 86.91 (2.22) 74.17 (5.16) 4.465* .018 .376 
Note. Mean (SE) 
*p < 0.05. 
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Manual drivers from both the medicated and unmedicated ADHD 
groups performed better across measures than those who drove an 
automatic vehicle. Compared to automatic drivers (n = 9), manual drivers 
(n = 6) amongst the medicated ADHD group scored significantly higher on 
measures of hazard detection; t(13) = -2.232, p = .045, r = .541, and 
overall performance; t(13) = -2.503, p = .026, r = .570. Manual driving was 
also associated with better use of signals (r = .504), and greater levels of 
passenger comfort (r = .457), however these differences were not 
statistically significant. Amongst the unmedicated ADHD group, manual 
drivers (n = 6) maintained significantly safer following distances than 
automatic drivers (n = 6); t(10) = -3.315, p = .016,  r = .724. They also 
tended to perform better than automatic drivers on measures of signalling 
(r = .442), and overall performance (r = .416). These differences did not 
reach statistical significance. 
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Environment. 
To investigate the impact of environmental demand on 
performance, each route involved driving in rural, residential, urban, and 
highway driving environments. Demand was low during driving in rural 
and highway environments, and highest during urban driving. Overall 
performance scores within each of the four driving environments were 
calculated for all participants. The resulting rural, residential, urban, and 
highway performance scores were then standardised by subtracting the 
overall performance mean (across groups and environments), and 
dividing by the standard deviation. Figure 4 presents standardised group 
performance means within each driving environment.  
!
!
While performance apparently declines as demand decreases 
amongst the medicated and unmedicated ADHD groups, separate one-
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way ANOVAs indicated the effect of environment on overall performance 
was not statistically significant. 
Whether environmental demand would significantly impact 
inattentive, impatient, and aggressive driving errors was then explored. 
Observer-reported engagement in inattentive, impatient, and aggressive 
errors during rural, residential, urban, and highway driving were 
calculated. Error rates within each driving environment were then 
subtracted from the unstandardized measure of performance within the 
relevant driving environment. Thus, rural driving errors were subtracted 
from the unstandardized measure of rural driving performance, and so on. 
Lower scores indicate increased impairment to performance as a result of 
the relevant driving error. Impaired performance scores as a result of 
inattentive, impatient, and aggressive driving within each environment are 
presented in Figure 5. 
!
 
A 3 (Group) x 4 (Environment) MANOVA was then conducted to 
examine group differences across the four driving environments related to 
inattentive, impatient, and aggressive driving errors. Using Wilks’ statistic, 
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a significant effect of group; Λ%= .796, F(6, 324) = 6.520, p < .001, and 
environment; Λ%= .839, F(9, 394) = 3.280, p = .001 was shown. A 
significant multivariate effect across the interaction of group and 
environment was also shown; Λ = .768, F(18, 458) = 2.497, p = .001. 
Univariate independent one-way ANOVAs revealed significant main 
effects of group on inattentive; F(2) = 4.756, p = .010, impatient; F(2) = 
13.438, p < .001, and aggressive; F(2) = 4.756, p = .003 errors. Significant 
main effects of environment were shown for inattentive; F(3) = 5.540, p = 
.001, and aggressive errors; F(3) = 3.256, p < .05, but not impatient 
errors. 
Environmental demand was not found to influence impaired 
performance amongst control group drivers, as suggested by the relative 
stability of mean scores across environments (see Figure 5). During urban 
driving, the performance of medicated and unmedicated ADHD 
participants was impaired least by inattentive errors. Impairment 
increased during residential and rural driving, and was most evident 
during highway driving for both the medicated and unmedicated ADHD 
groups. The effect of environment on inattentive driving was not 
statistically significant amongst the medicated ADHD group. Environment 
was found to significantly influence inattentive driving however amongst 
unmedicated ADHD drivers; F(3, 47) = 4.484, p = .008, ηp² = .443. More 
frequent engagement in inattentive errors during highway driving was 
found to significantly impair performance compared to driving in 
residential (p = .027) and urban (p = .003) environments.  
Although increased demand during urban driving encouraged 
minimal inattentive errors, engagement in impatient and aggressive 
driving errors was found to increase amongst unmedicated ADHD drivers. 
A trend for more frequent engagement in aggressive driving errors relative 
to that observed during rural (p = .084) and residential driving (p = .084) 
was revealed, however differences did not reach statistical significance. 
No significant effects of environment on impatient and aggressive driving 
were observed amongst the control and medicated ADHD groups. 
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Driver Aggression 
Bivariate correlations were calculated to investigate the 
relationship between self- and observer-reported driving aggression and 
performance. Amongst the control group, impatience correlated 
significantly with maintenance of unsafe speeds, r = -.50, p = .043, and 
involvement in crashes, r = .59, p = .012. Elevated self-reports of 
engagement in aggressive violations, and excessive speeding were 
associated with involvement in crashes (r = .56, p = .024). Excessive 
speeding was also significantly associated with involvement in crashes; r 
= -.81, p < .001, and at fault crashes; r = -.66, p = .004.  
Self-reported aggressive violations amongst the medicated ADHD 
group were associated with maintenance of unsafe speeds (r = -.77, p = 
.001), following distances (r = -.66, p = .011), and poorer overall 
performance (r = -.73, p = .003). Impatience was also associated with 
maintenance of unsafe speeds (r = -.98, p = .020) amongst the medicated 
ADHD group, and with passenger discomfort, r = .92, p = .004, poor gap 
selection, r = -.81, p = .029, and driving at unsafe speeds, r = -.85, p = 
.016 amongst unmedicated ADHD drivers. Aggressive errors amongst 
unmedicated ADHD driver were correlated with poor gap selection, r = -
.86, p = .013, and driving at unsafe speeds, r = -.83, p = .022. Aggressive 
violations were associated with maintenance of unsafe speeds (r = -.70, p 
= .011), following distances (r = -.69, p = .012), and poorer overall 
performance (r = -.81, p = .002). 
Diagnostic Type 
The effect of ADHD diagnostic subtype on within group driving 
performance was explored amongst medicated and unmedicated ADHD 
drivers using one-way ANOVA (see Figure 6). Compared to Combined 
type drivers amongst the medicated ADHD group, Predominantly 
Inattentive type drivers tended to maintain safer following distances (p = 
.077), and commit fewer errors related to impatience (p = .099). These 
differences did not reach statistical significance. Amongst the 
unmedicated ADHD group, diagnostic type was found to have a 
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significant effect on speed; F(2, 11) = 4.258, p = .050. Compared to 
Combined type drivers (M = 73.72, SE = 6.28), Predominantly Inattentive 
type drivers (M = 90.50, SE = 4.62) maintained significantly safer speeds 
on the road (p = .043). Predominantly Inattentive type drivers also tended 
to perform better on measures of passenger comfort (p = .083), and gap 
selection (p = .081) compared to Combined type drivers, however these 
differences did not reach statistical significance. 
 
 
Symptom presentation. 
To investigate the effects of inattentive and hyperactive/ impulsive 
symptoms on driving, bivariate correlations between symptom subscales 
of the CAARS and measures of driving performance were calculated (see 
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Table 9). Amongst the control group, problems with inattention were 
associated with poor observation, signalling, and hazard response, 
driving in excess of the speed limit, and poor overall performance. 
Elevated symptoms of hyperactivity and impulsivity were related to 
maintenance of unsafe following distances and speeds, and poor overall 
performance.  
Amongst medicated ADHD drivers, elevated symptoms of 
hyperactivity and impulsivity were associated with poor use of indicators, 
and driving in excess of the speed limit. Hyperactivity and impulsivity 
correlated negatively with engagement in inattentive errors, and positively 
with impatient errors. Elevated symptoms of both inattention and 
hyperactivity and impulsivity were associated with poor observation, 
however correlations did not reach statistical significance. 
 
 
Inattentive and hyperactive impulsive symptom presentations were 
associated with contrasting performance scores amongst the 
unmedicated ADHD group. While inattentive symptoms were significantly 
associated with safe following distances on the road, drivers who 
reported elevated symptoms of hyperactivity and impulsivity tended to 
Table 9!
Pearson correlations between ADHD symptom severity (CAARS) and measures of on road performance 
 Control 
 Medicated ADHD  Unmedicated ADHD 
 Inattentive Hyperactive  
 Inattentive Hyperactive   Inattentive Hyperactive 
Observation -.60* -.32  -.33 -.42  .17 -.21 
Following Distance -.41 -.57*  -.18 -.37  .58* -.65* 
Signalling -.55* -.02  -.00 -.51*  -.03 -.44 
Gap Selection .06 -.17  .64** .54*  .40 -.39 
Hazard Detection -.14 .02  .62* .44*  .50 -.17 
Hazard Response -.71** -.27  .05 .34  -.17 -.36 
Speed -.64** -.48*  -.26 -.63*  .42 -.54* 
Overall Performance -.74*** -.52*  .28 -.01  .38 -.50* 
Inattentive errors .34 .43  .03 -.54*  .12 .73** 
Impatient errors .34 -.00  .36 .68**  -.56* .56* 
Aggressive errors -.07 .22  .08 .36  -.71** .36 
         
Note. Pearson’s r.  Inattentive and Hyperactive/ Impulsive Subscales of the CAARS-S: L.  
*p < 0.05. **p < 0.01. !!!
Table 5 
Logistic regression of the effects of group, age, and driving experience on involvement in multiple crashes 
     
95% CI  
Step 1 B (SE) Wald df p Lower Odds Ratio Upper 
Group  6.42 2 .040    
Medicated ADHD (1) 2.72  (1.18) 5.35* 1 .021 1.52 15.19 152.22 
Unmedicated ADHD (2) 2.94  (1.20) 5.97* 1 .015 1.79 18.96 200.81 
Age 0.59  (0.43) 1.86 1 .173 0.77 1.80 4.18 
Experience -0.00  (0.00) 0.69 1 .406 0.99 1.00 1.00 
Constant -3.04  (1.15) 6.94** 1 .008  0.05  
        
Note. CI = confidence interval.   
R2 = .290 (Cox & Snell), .397 (Nagelkerke). 
*p < 0.05. **p <0.01. !!!
Table 4 
Overall driving performance and error scores by group 
 Control (n = 17) 
Medicated ADHD 
(n = 15) 
Unmedicated ADHD 
(n = 12) F(2, 41) p ηp² 
Overall performance 88.10 (1.91) 91.84 (1.32) 83.26 (3.19) 3.721* .033 .332 
Inattentive errors 1.47 (0.26) 1.50 (0.29) 2.83 (0.49) 4.797* .013 .384 
Impatient errors 0.71 (0.27) 0.67 (0.24) 2.92 (0.70) 9.095*** < .001 .519 
Aggressive errors 0.47 (0.26) 0.23 (0.11) 1.42 (0.70) 2.473 .097 .251 
Total errors 2.65 (0.49) 2.40 (0.47) 7.17 (1.41) 10.301*** < .001 .545 
       
Note. Mean (SE) 
*p < 0.05. **p < .01. ***p < .001. 
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maintain unsafe following distances. Measures of gap selection, hazard 
detection, speed, and overall performance were also found to correlate 
positively with symptoms of inattention, and negatively with symptoms of 
hyperactivity and impulsivity, indicating poorer performance amongst 
those who reported elevated symptoms of hyperactivity and impulsivity. 
Several of these correlations did not reach statistical significance. 
Elevated inattentive symptoms were significantly associated with 
reduced engagement in impatient and aggressive driving errors. 
Symptoms of hyperactivity and impulsivity however were found to 
correlate significantly with engagement in impatient errors on the road. A 
trend for increased engagement in aggressive errors was also observed, 
but did not reach statistical significance. 
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Discussion 
This is the first known study to investigate ADHD driver 
performance as a function of naturally occurring influences of demand 
and arousal in real traffic. Returning to the research questions, it was 
hypothesised that impaired driving would present most amongst ADHD 
drivers relative to controls. Treatment was expected to result in improved 
performance amongst medicated ADHD drivers compared to those who 
were not medicated. It was secondly hypothesised that group differences 
in self-reported risky driving and driving history, and in the congruence of 
self and observer-report would present. Environmental factors impacting 
task demand, such as vehicle transmission, and driving environment were 
expected to influence performance amongst drivers with ADHD 
particularly. It was finally hypothesised that driver aggression would be 
associated with poorer driving outcomes, and although largely 
unexplored, that distinct driving styles would be revealed amongst the 
Predominantly Inattentive and Hyperactive-Impulsive subtypes of ADHD. 
In keeping with the predicted outcomes, unmedicated ADHD was 
associated with significantly worse driving performance in real traffic 
compared to controls. Unmedicated ADHD drivers were more likely to 
commit driving errors on the road than were drivers amongst the 
medicated ADHD and control groups. Most often these errors were the 
result of inattention or impatience. Treatment was associated with better 
driving performance and less frequent engagement in driving errors. 
Driving performance scores amongst medicated ADHD drivers were 
comparable to, if not better than, those of the control group. 
While the hypothesised differences in self-reported infringement 
history were not found, unmedicated ADHD drivers did report 
involvement in more crashes than drivers without ADHD, and a trend for 
involvement in more crashes in which they were found to be at fault. This 
is consistent with previous findings (Merkel et al., 2013; Murphy & 
Barkley, 1996). It was also revealed that medicated ADHD drivers were 
15.19 times more likely; and unmedicated ADHD drivers 18.96 times 
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more likely to be involved in multiple collisions across the lifetime than 
were controls.  
Both ADHD driver groups reported elevated frequencies of 
engagement in risky driving behaviours, with the medicated group 
reporting more frequent errors, lapses, and aggressive violations, and the 
unmedicated group reporting more aggressive violations and total risky 
driving behaviours compared to controls. In a previous study employing 
the three-factor DBQ, Fried et al. (2006) also obtained reports of more 
frequent engagement in errors, lapses, violations, and total risky driving 
behaviours from ADHD drivers relative to controls.  
Despite reporting similar frequencies of risky driving, medicated 
ADHD drivers were observed engaging in significantly fewer risky 
behaviours on the road than were drivers amongst the unmedicated 
ADHD group. Comparisons of self- and observer-reported measures 
suggest the driver groups tend to perceive and report the extent to which 
they engage in risky behaviours differently. While the medicated group 
largely overestimated the severity and frequency of their risky driving, 
unmedicated ADHD drivers tended to associate less risk with their own 
risky driving compared to observer-reports. Control group drivers were 
able to recognise their tendencies for attentional lapses on the road, but 
apparently underestimated or were unaware of their engagement in 
aggressive driving errors.  
Underreporting of engagement in risky driving behaviours amongst 
ADHD drivers was related to poorer overall driving performance in the 
present study. While impaired risk perception and positive illusory bias 
was apparent amongst unmedicated ADHD drivers, medicated drivers 
demonstrated elevated awareness of their tendencies for risky driving, 
even in comparison to the control group. This suggests that stimulant 
treatment might also mitigate impairments of risk perception evident 
amongst unmedicated drivers. 
Further exploration of driving skills revealed poor observation and 
gap selection amongst unmedicated ADHD drivers, and more frequent 
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speeding in relation to medicated ADHD drivers. A tendency for poorer 
performance compared to controls was also observed across measures 
with just one exception. ADHD drivers from both the medicated and 
unmedicated ADHD groups demonstrated excellent hazard response 
skills. While controls tended to identify hazards effectively, responses to 
those hazards were more likely to be less effective than those of ADHD 
drivers. This finding might be related to the resulting changes in task 
demand during hazard situations. In the same way that researchers have 
utilised auditory white noise (Söderlund et al., 2007), and more difficult 
driving challenges (Reimer et al., 2010) to increase load, task demand 
may also increase when a potentially threatening situation is presented in 
the driving environment, hence increasing driver arousal, and resulting in 
a more effective hazard response amongst drivers with ADHD. 
Several influences of task demand were found to significantly 
effect performance amongst ADHD drivers. Coinciding with the findings 
of Cox and colleagues (2006a), drivers of vehicles with a manual 
transmission performed better than drivers of automatic vehicles amongst 
the ADHD groups. Manual driving was associated with better hazard 
detection skills, greater levels of passenger comfort, and more 
appropriate use of indicators amongst medicated ADHD drivers, and 
safer following distances and more appropriate use of indicators amongst 
unmedicated ADHD drivers. 
Several participants from the medicated and unmedicated ADHD 
groups noted without any suggestion that they preferred to drive a 
manual transmission vehicle because it was more engaging, or because 
they had noticed their mind would wander less compared to when driving 
an automatic. This may have influenced the increased proportion of 
manual vehicles amongst the unmedicated ADHD group (50%), 
compared to controls (28%). 
The driving environment was also found to significantly influence 
driving performance and errors amongst ADHD drivers. Drivers from both 
the medicated and unmedicated groups were able to sustain attention to 
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the driving task best during urban driving, resulting in reduced impairment 
to performance as a result of inattentive errors. Inattentive errors 
increased during residential and rural driving, and were most frequent 
during highway driving. This supports the hypothesised influence of 
environmental demand on attention and performance. As environmental 
demand decreased, drivers with ADHD, particularly those that were 
unmedicated, demonstrated increased difficulties with sustained 
attention. 
Impatient and aggressive errors were found to occur during 
periods of sustained attention to the driving task amongst the 
unmedicated ADHD group. Driving aggression was related to more 
frequent involvement in crashes, and at fault crashes. This supports the 
hypothesised increase in adverse outcomes amongst drivers who 
demonstrate aggressive driving styles or behaviours.  
It was also revealed that diagnostic subtypes of ADHD were 
related to differing driving styles and impairments. Though associated 
with poorer hazard response amongst both the medicated and 
unmedicated ADHD groups, participants reporting elevated symptoms of 
inattention also maintained safer speeds and following distances, and 
engaged in fewer impatient and aggressive driving errors on the road. 
Symptoms of hyperactivity and impulsivity were associated with poor gap 
selection, and more frequent impatient errors amongst medicated drivers, 
and driving at unsafe speeds, passenger discomfort, and poor gap 
selection skills amongst unmedicated ADHD drivers. Further, drivers 
diagnosed as Hyperactive-Impulsive or Combined type ADHD more 
frequently travelled at speeds in excess of the speed limit, maintained 
unsafe following distances, and engaged in errors attributable to 
impatience and aggression on the road. 
The apparently divergent presentation of subtype driving styles 
calls for differential management of on-road risk. It might benefit drivers 
diagnosed as Hyperactive/ Impulsive or Combined type ADHD to be 
mindful of the increased likelihood for venting behaviours after periods of 
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frustrating, or low-stimulus driving. Venting may manifest as impulsive 
and aggressive driving violations such as dangerous overtaking. Such 
risk-taking behaviours serve as self-stimulation when arousal is low. 
Drivers diagnosed as Predominantly-Inattentive type ADHD however are 
much less predisposed toward impulsive driving acts. Adverse outcomes 
amongst this subgroup of drivers are more likely to result from attentional 
lapses during low stimulus driving. Awareness of specific vulnerabilities to 
poor driving outcomes amongst ADHD subtypes, and recognition of the 
role of environmental factors in shaping such vulnerabilities, is imperative 
for development of effective and novel strategies of intervention.  
Limitations 
The results should be considered in light of several limitations. 
Difficulty recruiting diagnosed ADHD drivers meant that gender could not 
be balanced between groups. As a result, the unmedicated ADHD group 
consisted predominantly of male drivers (75%). The recruited sample is a 
direct reflection however of those who volunteered to participate, and is 
consistent with estimates that males represent between 66% and 90% of 
all paediatric diagnoses of ADHD (Biederman, Faraone, Monuteaux, 
Bober, & Cadogen, 2004; Coles, 2012; Ohan & Visser, 2009).  
Comorbid depression has been linked with reduced 
responsiveness to stimulant treatment amongst individuals with ADHD 
(Sobanski, 2006). The prevalence of depression was high amongst 
stimulant treated ADHD drivers (41.7%), thus the reported performance 
means amongst this group may not represent the full efficacy of 
treatment. A high prevalence of depression was also evident amongst 
unmedicated ADHD participants (66.7%) compared to controls (5.7%), 
and is consistent with rates reported in a recent study of comorbidities 
amongst New Zealand adults with ADHD (Rucklidge, Downs-Woolley, 
Taylor, Brown, & Harrow, 2014).  
Comparisons of self- and observer-reports revealed group 
discrepancies in the way drivers perceive and report the extent to which 
they engage in risky behaviours. Thus, validating self-reports through 
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attainment of an objective measure of driving history would have 
facilitated more confident assertion of the presenting group differences.  
Despite these considerations, this study has established several 
important influences of performance amongst ADHD drivers seldom 
explored in research to date. This research is the first to document the 
impact of cognitive factors influencing task demand on the performance 
of drivers with ADHD in real traffic. While it has been indicated that drivers 
with ADHD are capable of resisting distraction when task demand is high 
(Biederman et al., 2012b; Reimer et al., 2010), and that demand can be 
manipulated to encourage such outcomes (Cox et al., 2006b; Forster et 
al., 2014), the present study was the first to utilise naturally occurring 
influences of demand within the driving environment, and to demonstrate 
a significant interaction of demand and driving performance amongst 
drivers with ADHD in real traffic.  
Conclusion 
Corroborating previous findings related to the elevated risk for 
adverse road safety outcomes, unmedicated ADHD drivers were found to 
employ fewer safe driving behaviours, and engage more frequently in 
inattentive and impatient driving behaviours relative to controls. Amongst 
drivers treated for ADHD however, performance was comparable to, if not 
better than, that of the control group, attesting further to the efficacy of 
pharmacological treatments in ameliorating driving impairments. 
Drivers with ADHD reported involvement in more crashes, and 
engaging in more frequent risky driving behaviours compared to controls. 
Comparisons of self- and observer-reported measures were suggestive of 
group discrepancies in the way drivers perceive and report engagement 
in risky behaviours on the road. While medicated ADHD drivers largely 
overestimated the severity and frequency of their risky driving behaviour, 
unmedicated ADHD drivers tended to associate less risk with their own 
driving behaviours compared to observer-reports. 
Most significantly, the present study was able to register the 
impact of cognitive factors influencing task demand on ADHD driver 
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performance in real traffic. Driving environment was found to significantly 
effect performance and errors amongst ADHD drivers. Attention to the 
driving task was best during high demand, urban driving. As 
environmental demand decreased however, unmedicated ADHD drivers 
in particular experienced increased difficulty attending to the driving task, 
resulting in more significant impairments to driving performance. 
Transmission was also found to influence performance amongst ADHD 
drivers, several of whom noted their preference for driving vehicles with a 
manual transmission because it was more engaging, or because they had 
noticed their mind would wander less compared to when driving an 
automatic vehicle. Manual driving was associated with better hazard 
detection skills, greater levels of passenger comfort, and more 
appropriate use of indicators amongst medicated ADHD drivers, and 
safer following distances and more appropriate use of indicators amongst 
unmedicated ADHD drivers.  
These findings further support the critical role of task demand in 
determining the ability of an individual with ADHD to focus attention in the 
presence of distractor stimuli. Under high demand driving conditions, 
individuals with ADHD may become fully engaged in the processing of the 
driving task, with minimal perception of distractor stimuli. Practical 
intervention strategies that are able to effectively engage this finding; 
such as choosing to drive a vehicle with a manual transmission, will 
present a plausible means of relieving the undermining impacts of 
distraction on ADHD driver performance, hence also encouraging more 
optimal outcomes for this established high risk driving population.  
The present study also revealed an apparent distinction between 
the driving styles of individuals presenting Predominantly Inattentive, and 
Hyperactive-Impulsive subtype symptomologies. Further research is 
necessary however to establish this link, and should target behaviours 
that relate to the crux symptoms of each subtype, utilising real driving 
situations and objective measures of arousal, attention, and aggression, 
given that ADHD and non-ADHD drivers appear to report conflicting 
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engagement in aggressive driving behaviours compared to observer-
reports. Better recognition of specific vulnerabilities on the road will also 
engender development of more pertinent, hence effective, modes of 
symptom specific intervention.  
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